Market regulator, Securities and Exchange Board of India (SEBI) imposed fines on two former executives of the global pharma company Workhardt totalling Rs 13 lakh...
On July 31, Gland Pharma’s share price surged 5.49% to Rs 1,365 after the company acknowledged a zero-observation certificate from the US drug regulator for...
Pharmaceutical major Lupin announced that the drug maker had received six observations from USFDA for its Unit 2 plant in Pithampur, Indore on 26 January....
Unichem Laboratories has got two observations from USFDA for its formulation facility at Ghaziabad, Uttar Pradesh. The US drug regulator has inspected the facility from...